新型光子计数探测器CT增强扫描中的贫血检测与定量:一项前瞻性概念验证研究
本前瞻性研究纳入329例肿瘤患者,在新型光子计数探测器CT增强扫描的VNC序列上测量血池CT值,并与血清血红蛋白值进行相关性分析。结果显示血池VNC CT值与血红蛋白呈强线性相关(r²=0.80),基于性别特异性阈值识别无贫血、轻中度贫血及重度贫血的AUC均大于0.90。
要点
- 光子计数探测器CT增强扫描的VNC序列血池CT值与血清血红蛋白强相关(r²=0.80)。
- 基于性别特异性VNC血池CT值阈值,识别贫血各程度的AUC均大于0.90。
- 该技术可在肿瘤患者增强CT中同时实现贫血的检测与定量。
核心结论
- 光子计数探测器CT增强扫描的光谱信息可高诊断准确度地检测和定量肿瘤患者的贫血。
研究设计与样本
- 前瞻性概念验证研究(NCT04989192),纳入2021年8月至2022年1月间连续接受新型光子计数探测器CT增强扫描的肿瘤患者329例(年龄68±12岁,男性200例),全血细胞计数与CT扫描间隔不超过7天。
诊断标准与关键数值
- 在70 keV VMI序列和VNC序列上于左心房、左心室、主肺动脉、升主动脉和降主动脉五个解剖位置测量血池CT值并取每例患者平均值;VNC血池CT值与血红蛋白r²=0.80(p<.001)、与血细胞比容r²=0.76(p<.001);按WHO贫血分级(无贫血、轻度、中度、重度),男女贫血亚组间VNC血池CT值差异ΔHU为3.5–11.4(均p<.01);采用性别特异性VNC血池CT值阈值识别无贫血、无贫血合并轻度贫血及重度贫血患者的AUC均大于0.90。
临床应用与阅片要点
- 在肿瘤患者增强CT扫描中,可利用光子计数探测器CT的VNC序列血池CT值辅助检测和定量贫血,阈值需按性别区分。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To correlate CT values of the blood pool on VNC series with serum hemoglobin values for the detection of anemia in oncologic patients undergoing contrast-enhanced PCD-CT scans.
METHODS: This prospective study (NCT04989192) included consecutive oncologic patients undergoing contrast-enhanced CT on a novel PCD-CT system between 08/2021 and 01/2022. The interval between complete blood count (CBC) and CT scan acquisition had to be no more than seven days. CT-values of the blood pool were measured on 70 keV VMI series (CT-values(BP)70keV) and on VNC series (CT-values(BP)VNC) at five anatomic positions (left atrium, left ventricle, main pulmonary artery, ascending and descending aorta) and averaged per patient. Pearson correlation analyses and ROC analyses were performed to identify relations between CT-values(BP)VNC, CBC parameters, and degrees of anemia as defined by the WHO (no anemia, mild, moderate, severe anemia).
RESULTS: A total of 329 patients (age 68 ± 12 years; 200 men) were included. CT-values(BP)VNC showed a strong linear correlation to serum hemoglobin (r2 = 0.80, p <.001) and hematocrit (r2 = 0.76, p <.001) and were significantly different between anemia subgroups in both women and men (ΔHU: 3.5-11.4; all p <.01). ROC analyses yielded high diagnostic performance for the identification of patients without anemia, patients without and with mild anemia, and patients with severe anemia using gender-specific cutoffs for CT-value(BP)VNC (all AUC's > 0.90).
CONCLUSIONS: The spectral information inherent in PCD-CT acquisitions allows the detection and quantification of anemia in contrast-enhanced CT acquisitions of oncologic patients with high diagnostic accuracy.
引用
- Decker JA, Huber A, Senel F, et al. Anemia detection and quantification in contrast-enhanced CT scans on a novel photon-counting detector CT: A prospective proof-of-concept study. Eur J Radiol. 2023. PMID: 37487433. doi:10.1016/j.ejrad.2023.110967
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。